USC patient RNA-Seq data shows potential of ANGLE’s Parsortix liquid biopsy for metastatic breast cancer screening

April 21, 2016 Leave a comment 2,451 Views

ANGLE plc , the specialist medtech company, has announced that the results of the University of Southern California (USC) Norris Comprehensive Cancer Center’s ongoing work with ANGLE’s Parsortix system have demonstrated the potential for the use of Parsortix as a ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: cancer screening

USC patient RNA-Seq data shows potential of ANGLE’s Parsortix liquid biopsy for metastatic breast cancer screening

Mim-tRNAseq – A method that accurately measures the abundance and modification status of different tRNAs

Uncovering the Anti-Myeloma Resistance Files

Long term and short-term effects of RNA fixation on Single Cell RNA Sequencing

Single cell RNA sequencing opens new avenues for eradicating leukaemia at its source

2passtools: two-pass alignment using machine-learning-filtered splice junctions increases the accuracy of intron detection in long-read RNA sequencing

scRNA-Seq reveals a new type of bone cell that may uncover therapeutic targets for a range of skeletal diseases

DEBKS – a tool to detect differentially expressed circular RNA